Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden
Clinical trial NCT03671720 · WITHDRAWN
Trial details
- NCT number
- NCT03671720
- Sponsor
- Capital Medical University
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-11
- Primary completion
- 2021-12-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.